HologenAI
AI models for healthcare based on real-world data.
Hologen Limited specialises in building AI models from real-world data for use in healthcare.
Their technology can be applied to Phase 2 and 3 clinical trials to enable accurate quantification of therapeutic effects, and illuminates disease mechanisms opaque to conventional models, revealing new therapeutic and commercial opportunities.
The HologenAI journey so far:
- Founded in 2025
Dr Caitriona O'Rourke (Away from office)
Senior Business Manager
Dr O'Rourke has worked as a research associate on tissue engineering, drug delivery, regenerative medicine and stem cell biology. Her PhD looked at tissue engineering and her MSc in neuropharmacology.